FDA.reportPublic FDA data

amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet

RxCUI
1739831
RxNorm name
amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet
Display name
amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet
Full name
amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Adzenys XR-ODTAMPHETAMINENeos Therapeutics Brands, LLCc1179269-00b5-48ea-972d-31e614e99b7e2026-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1739831
Amphetamine Extended-ReleaseAMPHETAMINE EXTENDED-RELEASENeos Therapeutics, LP48d0f55c-f847-4d26-b2ed-94b5a27702282025-09-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1739831
AmphetamineAMPHETAMINETeva Pharmaceuticals, Inc.243e88e7-6621-47e9-8d5c-3f79bcb088bb2025-09-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1739831

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c1179269-00b5-48ea-972d-31e614e99b7eamphetamine 6.3 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 6.3 MG Extended Release Oral Tablet [SCD] · amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]315These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 196020260506
48d0f55c-f847-4d26-b2ed-94b5a2770228amphetamine 6.3 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 6.3 MG Extended Release Oral Tablet [SCD] · amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]35These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS . AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS, CII Initial U.S. Approval: 196020250924
243e88e7-6621-47e9-8d5c-3f79bcb088bbamphetamine 6.3 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 6.3 MG Extended Release Oral Tablet [SCD] · amphetamine 6.3 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]32These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS. AMPHETAMINE extended-release orally disintegrating tablets, CII Initial U.S. Approval: 196020250901